Why participate?

As a participating clinician, data acquired from PCOR-TAS will influence research, development and education. The benefits can include:

  • A cross-sectional view of multiple clinical and demographic aspects of prostate cancer that may be studied in detail using targeted, prospective study design or using health statistics.
  • Identifies whether clinicians are managing the disease in accordance with the principles of evidence-based practice.
  • Collects up-to-date information about patterns of care and enables oversight of changing patterns of disease demographic and management.
  • Enables clinicians to compare their own patient population and therapeutic management with that of other clinicians (NB. No clinician identifying information will be released by the PCOR-ANZ).
  • May be used to assist in the design of clinical trials, including identifying questions for study.
  • Provide clinicians and institutions with mortality and morbidity data associated with various risk and treatment groups, both for their own patients and the wider cohort of men with prostate cancer.
  • May be used as an educational tool for clinicians and students.

How to participate

Only clinicians working within contributing hospitals are eligible to enrol in the PCOR-TAS While enrolment is voluntary, it is important that the registry collects information from close to, if not all, the eligible population. The registry would serve limited purpose if it did not collect representative data from both patients and clinicians.